Table 1

 Acute rheumatic fever/rheumatic heart disease (ARF/RHD) register: example of priority based guidelines*

*Adapted from the Northern Territory Rheumatic Heart Disease Register 2003, with permission.
Priority 1: severe disease
Established RHD with any of:
• A valvar lesion that is severe
• A moderate to severe valvar lesion where left ventricular (LV) function is impaired or LV size is increased
• A moderate to severe valvar lesion where there is shortness of breath, tiredness, oedema, angina, or syncope
• History of bioprosthetic valve replacement (porcine or homograft), valve repair, valvotomy or metallic prosthetic valve replacement (until stabilised)
Management:
• Management by a cardiologist and consideration for surgery
• Patients should be reviewed every 6 months by a specialist physician or paediatrician
Priority 2: moderate disease
Established RHD with any of:
• A valvar lesion that is moderate, providing there are no symptoms and left ventricular function is normal
• Mechanical prosthetic valves once stable following surgery
• A child or adolescent with a history of chorea until 18 years old, even if there is no valve damage (>50% will subsequently develop valve disease)
Management:
• Managed by primary care doctor with review by specialist physician/paediatrician every year (or earlier if clinical deterioration) or within 3 months of hospital discharge following any episode of confirmed or suspected ARF
• Echocardiogram recommended every year (children) or 2 years (adults) to assess valve lesion severity and LV function
Priority 3: mild disease
RHD or ARF:
• A valvar lesion that is trivial to mild
• History of ARF with no evidence of RHD
Management:
• Managed by primary care doctor unless clinical deterioration. Children and adolescent up to 18 years reviewed every year by a specialist physician or paediatrician
• Echocardiogram every 2 years (children) or 5 years (adults, no recent ARF).
• Any new diagnosis of ARF always requires specialist physician/paediatrician follow up within 3 months of hospital discharge to assess progress
• Specialist physician review before ceasing secondary prophylaxis